Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Non-cash Items (2023 - 2025)

Historic Non-cash Items for Abeona Therapeutics (ABEO) over the last 6 years, with Q3 2025 value amounting to $5000.0.

  • Abeona Therapeutics' Non-cash Items fell 3750.0% to $5000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5000.0, marking a year-over-year decrease of 3750.0%. This contributed to the annual value of $6000.0 for FY2024, which is 9556.45% down from last year.
  • Abeona Therapeutics' Non-cash Items amounted to $5000.0 in Q3 2025, which was down 3750.0% from $6000.0 recorded in Q2 2025.
  • Abeona Therapeutics' 5-year Non-cash Items high stood at $151580.0 for Q2 2024, and its period low was $3000.0 during Q4 2023.
  • In the last 3 years, Abeona Therapeutics' Non-cash Items had a median value of $6000.0 in 2024 and averaged $24572.5.
  • In the last 5 years, Abeona Therapeutics' Non-cash Items surged by 10000.0% in 2024 and then plummeted by 9604.17% in 2025.
  • Quarter analysis of 3 years shows Abeona Therapeutics' Non-cash Items stood at $3000.0 in 2023, then surged by 100.0% to $6000.0 in 2024, then fell by 16.67% to $5000.0 in 2025.
  • Its last three reported values are $5000.0 in Q3 2025, $6000.0 for Q2 2025, and $3000.0 during Q1 2025.